From GlobeNewswire: 2025-04-22 03:10:00

Sirona Biochem Corp. has secured a strategic investment agreement with Promura GmbH, a German-based investor, involving a $3 million CAD private placement of 12% convertible debentures. The agreement includes plans to form a new subsidiary, Sirona Laboratories, focused on dermatological and cosmetic innovation. Promura has expressed interest in investing up to $12 million CAD in Sirona Labs, pending due diligence. The partnership aims to accelerate the commercialization of Sirona’s anti-aging product line, signaling a significant step in the company’s growth and development. This investment will also support ongoing research, development, and the completion of audited financial statements.

For more information, visit www.sironabiochem.com.



Read more at GlobeNewswire: Sirona Biochem Secures Strategic Investment Agreements and